首页> 外文期刊>Oncology Research >The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a
【24h】

The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a

机译:通过抑制miR-33a,LNCRNA CCAT1上调对黑色素瘤细胞的增殖和侵袭

获取原文
获取原文并翻译 | 示例
       

摘要

It is increasingly evident that various long noncoding RNAs (lncRNAs) participate in the tumorigenesis of multiple tumors, including melanoma. lncRNAs have been validated as oncogenic factors in various tumors; however, the potential regulatory mechanism of CCAT1 in melanoma is still unclear. The purpose of this study was to investigate the regulation of CCAT1 on melanoma genesis. The expression of CCAT1 in melanoma tissue and cell lines was measured using qRT-PCR. Interference oligonucleotide or mimic sequences were applied to up- or downregulate RNA expression. CCK-8 and colony formation assays were performed to detect the proliferation capability. Transwell assay was used to assess the migration and invasion capacities. Bioinformatics analysis was performed to predict the target miRNAs of CCAT1. Expression of CCAT1 was significantly upregulated in melanoma tissue and cell lines. CCA:11 knockdown observably suppressed the proliferation, migration, and invasion abilities. Bioinformatics analysis predicted that miR-33a acted as a target of CCAT1, which was confirmed by dual-luciferase reporter assay. CCAT1 knockdown reversed the tumor-promoting ability of the miR-33a inhibitor. CCAT1 acts as an oncogenic factor in the genesis of melanoma and exerts tumor-promoting roles via sponging miR-33a, providing a novel insight for competing endogenous RNA (ceRNA) in the tumorigenesis of melanoma.
机译:越来越明显地明显,各种长的非编码RNA(LNCRNA)参与多种肿瘤的肿瘤引起,包括黑色素瘤。 LNCRNA已被验证为各种肿瘤的致癌因素;然而,CCAT1在黑素瘤中的潜在调节机制仍然尚不清楚。本研究的目的是探讨CCAT1对黑色素瘤起源的调节。使用QRT-PCR测量CCAT1在黑素瘤组织和细胞系中的表达。将干扰寡核苷酸或模拟序列施加到上调或下调RNA表达。进行CCK-8和菌落形成测定以检测增殖能力。 Transwell测定用于评估迁移和侵袭能力。进行生物信息学分析以预测CCAT1的靶miRNA。 CCAT1的表达在黑色素瘤组织和细胞系中显着上调。 CCA:11敲低可观察地抑制了增殖,迁移和入侵能力。生物信息学分析预测,miR-33a作用为CCAT1的靶标,通过双荧光素酶报告结果确认。 CCAT1敲低逆转MIR-33A抑制剂的肿瘤促进能力。 CCAT1作为黑素瘤的成因的致癌因子,通过海绵MIR-33A施加肿瘤促进作用,提供了对黑色素瘤的肿瘤瘤中竞争内源性RNA(Cerna)的新颖洞察力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号